Joshua McGee
Chief Scientific Officer & Co-Founder Keylicon Biosciences
Dr. Joshua McGee is the Chief Scientific Officer and Co-Founder of Keylicon Biosciences, where he leads development of next-generation vaccines and therapeutics across diverse targets. He earned his PhD in Biomedical Engineering from Boston University, where he developed modified self-amplifying RNA platforms, engineering lipid nanoparticle formulations, and designed novel saRNA vaccines and therapeutics.
Seminars
Tuesday 21st July 2026
Overcoming the Innate Immune Response of Self-Amplifying RNAs to Unlock Improved Vaccines & Therapeutics
4:15 pm
- The innate response to self-amplifying RNAs can by overcome by incorporating the right modified nucleotides
- Engineered saRNA vectors substantially increase protein expression, improving replication, stability, and translation
- Advanced vector designs unlock differentiated performance, enabling potent multivalent vaccines and tissue-specific therapeutic expression
